Observational studyAdvances in therapy2024

Updated Results from the Retrospective CREST Study on the Safety and Effectiveness of 8-Week Glecaprevir/Pibrentasvir in HCV-Infected Treatment-Naïve Patients with Compensated Cirrhosis.

Markus Cornberg et al.PubMed ↗Publisher ↗

No numbers read from the abstract.